Related Experiment Video
Updated: May 4, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Cytokeratin 7 as a predictive factor for response to concommitant radiochemotherapy for locally advanced cervical
Eric Lambaudie1, Elisabeth Chereau, Nicolas Pouget
1Service de Chirurgie Oncologique, Institut Paoli Calmettes, 232, bd Sainte Marguerite, 13009 Marseille, France. chereaue@ipc.unicancer.fr.
Background:
The role of completion surgery after concurrent radiochemotherapy (CCRC) for advanced cervical cancer remains controversial. Individual predictive factors of CCRC response and survival are mandatory for treatment adaptation and to determine a population who would take interest in completion surgery after CCRC. The aim of this study was to evaluate the ability of biomarkers to predict the response to CCRC.
Patients And Methods:
Between 1996 and 2008, in 58 patients with advanced cervical cancer for whom pre-therapeutic cone biopsy was available, we tested several biomarkers (ALDH1, CD44, CD24, IDO, Ki67, P63, CK7, p-Stat3, Foxp3 and IDO).
Results:
Residual disease was found in 49.1% of cases (n=26). We found a significant association between progression-free survival and residual disease on completion hysterectomy (p=0.044). Univariate analysis of the different factors showed that negativity for cytokeratin 7 expression was a strong predictor for the presence of residual tumor (p=0.001).
Conclusion:
These results are encouraging and CK7 could be used as a predictive factor of response to CCRC.
